AQR Capital Management - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$304,000
+130.3%
862,168
+367.4%
0.00%
Q1 2022$132,000
-28.6%
184,465
+125.6%
0.00%
Q4 2021$185,000
-11.9%
81,774
+12.4%
0.00%
Q3 2021$210,000
+296.2%
72,770
+419.1%
0.00%
Q2 2021$53,000
-60.2%
14,019
-64.3%
0.00%
Q1 2021$133,000
-76.2%
39,248
-80.4%
0.00%
-100.0%
Q4 2020$560,000
-39.3%
200,093
-45.5%
0.00%
-50.0%
Q3 2020$922,000
-70.4%
367,286
+60.3%
0.00%
-60.0%
Q2 2020$3,111,000
+89.0%
229,059
+5.5%
0.01%
+66.7%
Q1 2020$1,646,000
-12.4%
217,123
-27.0%
0.00%
+50.0%
Q4 2019$1,880,000
+434.1%
297,479
+231.4%
0.00%
Q3 2019$352,000
+551.9%
89,771
+701.8%
0.00%
Q2 2019$54,000
-75.0%
11,196
-50.5%
0.00%
Q1 2018$216,000
-63.5%
22,622
-43.2%
0.00%
-100.0%
Q4 2017$592,000
-41.7%
39,831
-22.8%
0.00%0.0%
Q3 2017$1,015,00051,6160.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,031,283$95,485,0005.72%
GREAT POINT PARTNERS LLC 3,510,073$47,667,0003.81%
Logos Global Management LP 1,200,000$16,296,0003.26%
DAFNA Capital Management LLC 762,666$10,357,0002.99%
Baupost Group 15,000,000$203,700,0002.54%
Nantahala Capital Management 6,101,111$82,853,0002.50%
Abrams Capital Management 5,656,462$76,815,0002.48%
Novo Holdings A/S 1,987,506$26,990,0001.74%
Stanley-Laman Group, Ltd. 316,933$4,304,0001.04%
Integral Health Asset Management, LLC 250,000$3,395,0001.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders